Treating biliary tract cancer (BTC) is a real challenge. While combining chemotherapy with drugs that target PD-1 protein (called PD-1 inhibitors) might work well, doctors need better ways to predict who will benefit the most. A team at Changzhou First People's Hospital decided to look into this. Th
Mobile stroke units, or MSUs, are becoming popular around the world for quickly treating strokes. They help reduce the time it takes to start treatment and may improve access to a procedure called mechanical thrombectomy. However, there's been no research in England and Wales to see if doctors, pati
Ever wondered how different SGLT-2 inhibitors stack up against each other? Well, the truth is, we don't know much. Most studies compare these diabetes drugs to placebos, not to each other. So, how effective and safe are individual SGLT-2 inhibitors? That's still a mystery. Let's break it down. SGLT
Have you ever heard of FXa inhibitors? These are medicines that help stop blood clots. But how do they affect kids? A recent study tried to figure this out by looking at what we call "adverse events" or AEs, which are side effects. The researchers did something called a meta-analysis, which is like
Imagine tiny waste disposal units inside your cells that aren't working right. Welcome to the world of lysosomal storage disorders (LSDs)—rare diseases that mess up these tiny units, called lysosomes. Normally, lysosomes break down big molecules like sugars and fats. But in LSDs, certain enzymes are
Have you ever wondered how what we eat and do can influence our mood? This is especially true for cancer patients, who often face depression. A recent study explored how a score called Oxidative Balance Score (OBS)—which considers diet and lifestyle—is linked to depression and specific symptoms in c
Ever wondered how a country decides the price of new medicines? Spain has been working on an update to how it evaluates and prices drugs for its National Health System (NHS). They've got a plan that stretches from 2019 to 2024. The Advisory Committee on Pharmaceutical Financing (CAPF) has shared som
Finding reliable ways to predict how metastatic kidney cancer patients will respond to treatment is a big deal. Doctors need this info to decide on the best care plan. One thing they're looking at is the glucose-to-lymphocyte ratio (GLR). This is like a sugar to immune cells ratio. A Turkish group c
Want to get reminders and set tasks without lifting a finger? ChatGPT's got you! Starting this week, paying users of ChatGPT Plus, Team, and Pro can ask the AI to handle their reminders and recurring tasks. Simply ask, "Remind me about my passport in six months, " and ChatGPT will send a push notifi
Imagine a tough, benign tumor that grows in your joints and often comes back even after surgery. That's diffuse-type tenosynovial giant cell tumor (dTGCT) for you. Scientists are on a mission to find better drugs to treat this sneaky tumor. They've been looking at a signaling pathway called JAK/STAT
